— Know what they know.
Not Investment Advice
Also trades as: CDTTW (NASDAQ) · $vol 0M

CDT NASDAQ

CDT Equity Inc.
1W: -50.5% 1M: +8.8% 3M: -78.2% YTD: -31.2% 1Y: -82.2% 3Y: -100.0%
$0.99
-0.26 (-20.80%)
 
Weekly Expected Move ±1052.8%
$-20 $-9 $1 $11 $22
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 28 · $763021 mcap · 343924 float · 34.74% daily turnover · Short 44% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Income Trends

Revenue
$2.7B +0.0% ▲
Gross Profit
$1.0B +225739.4% ▲
Operating Income
$316M +2147.4% ▲
Net Income
$238M +1434.2% ▲
EPS (Diluted)
$1477.50 +128.8% ▲
EBITDA
$316M +2093.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$2.7B
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$457K$1.7B
Gross Profit$0$0$0-$457K$1.0B
Gross Margin————38.0%
R&D Expenses$283K$111K$90K$3M$129M
SG&A Expenses$3M$3M$5M$12M$533M
Operating Expenses$3M$3M$5M$15M$662M
Operating Income-$3M-$3M-$5M-$15M$316M
Operating Margin————11.6%
Interest Expense$0$0$211K$2M-$46M
Income Before Tax-$4M-$5M$3M-$18M$267M
Tax Expense$0$0$0$0-$29M
Net Income-$4M-$5M-$535K-$18M$238M
Net Margin————8.7%
EPS (Diluted)$-1.01$-0.07$-3.60$-20.53$1477.50
EBITDA-$3M-$5M$3M-$16M$316M
Shares Outstanding5764M2M2M160840

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms